Ofer Reizes, PhD
Staff, Department of Cellular and Molecular Medicine, and Director, Research Core Services
Cleveland Clinic Lerner Research Institute
Ofer Reizes, PhD, is Staff in the Department of Cellular and Molecular Medicine, Director of Research Core Services at the Lerner Research Institute at the Cleveland Clinic, and Director of Skills Development for the NIH Center for Accelerated Innovations at Cleveland Clinic. Dr. Reizes received his PhD in molecular pharmacology at UT-Southwestern Medical Center at Dallas. He went on to complete a post-doctoral fellowship at The Children's Hospital Boston and Harvard Medical School. In 2001, Dr. Reizes was recruited by Procter & Gamble Pharmaceuticals, Inc. to lead drug discovery efforts in obesity and metabolic diseases, progressing several obesity targets from early discovery to pre-clinical evaluation. In 2006, Dr. Reizes joined the Cleveland Clinic, where he studies the interface between obesity and cancer. His team discovered that a fat tissue hormone, called leptin, causes cancer tumors to grow larger and promotes the survival of tumor-initiating cells also known as cancer stem cells. Dr. Reizes research has been published in Cell, The Journal of Clinical Investigation, and the Proceedings of the National Academy of Sciences. He has presented at multiple national and international meetings including the Endocrine Society and the American Diabetes Association. He is a co-inventor of a patent titled "Methods and Reagents for Regulating Obesity." He has consulted for several biotechnology companies.
End of main page content.